News - Events

This meeting will focus on advances in drug product formulation, and innovations in device design and development that can aid delivery. It will also include a discussion of new therapeutic applications such as the delivery of siRNA.

The Advanced Therapies Congress brings the life science community together to discuss the challenges of bringing ATMPs to market. The event covers each stage in the development of cell, gene and immunotherapy – from bioprocessing through clinical development to reimbursement and delivery to patients.

This event will bring together specialists within the industry to provide an insight into the sphere of regulation, new digital technology, human factor studies and innovative design and delivery systems in the pre-filled syringes industry.

This two-day conference will bring together representatives of the pharmaceutical and biotechnology industries and academic institutions to provide first-hand information on the latest oligonucleotide clinical candidates. It will also act as a platform for exchanging ideas on one of the biggest challenges facing the industry: how to deliver these new therapies.

This meeting will provide new information on the potential connectivity and software for medical devices and how these devices can be worn during clinical trials. Key regulatory updates and guidance will also be presented by regulatory, notified body and industry experts. The meeting will give a comprehensive outlook for this expanding field.

This third annual event will look at the insights that can be generated by the use of real-world data to evaluate the effectiveness of pharmaceuticals, and how this data can help industry, payers and healthcare professionals take decisions.  

This event brings together specialists within the pre-filled syringes industry to provide insight into regulation, new digital technology, human studies and systems for device design and delivery.

The pharmaceutical microbiology industry has seen many changes in recent years. These changes include the discovery of new methods for multiplying microbial organisms, enhanced knowledge of the human microbiome, and new regulation. This meeting will bring together experts from industry to discuss data integrity as it affects microbiology methods, environmental monitoring and automated endotoxin testing and process automation.

The aseptic processing industry, or the processing and packaging of a sterile product, has seen many changes. These are due to advances in manufacturing technology and the use of robotics and automation, to name a few aspects. In 2018, the global aseptic processing market was valued at more than $56 trillion. Revenue is expected to increase to around $124 trillion by 2027. The industry continues to adapt to innovative therapies and to demands to deliver treatments to patients faster. This meeting will examine the new technologies and how they will affect the industry.